Supplementary Data from the Deubiquitinase USP38 Promotes NHEJ Repair Through Regulation of HDAC1 Activity and Regulates Cancer Cell Response to Genotoxic Insults

Yongfeng Yang,Chuanzhen Yang,Tingting Li,Shuyu Yu,Tingting Gan,Jiazhi Hu,Jun Cui,Xiaofeng Zheng

DOI: https://doi.org/10.1158/0008-5472.22425465

2023-01-01

Abstract:Supplementary methods, Table S1,Figure S1-8 and legends

What problem does this paper attempt to address?

Data from The Deubiquitinase USP38 Promotes NHEJ Repair through Regulation of HDAC1 Activity and Regulates Cancer Cell Response to Genotoxic Insults

Yongfeng Yang,Chuanzhen Yang,Tingting Li,Shuyu Yu,Tingting Gan,Jiazhi Hu,Jun Cui,Xiaofeng Zheng

DOI: https://doi.org/10.1158/0008-5472.c.6512043.v1

2023-01-01

Abstract:AbstractThe DNA damage response (DDR) is essential for maintaining genome integrity. Mounting evidence reveals that protein modifications play vital roles in the DDR. Here, we show that USP38 is involved in the DDR by regulating the activity of HDAC1. In response to DNA damage, USP38 interacted with HDAC1 and specifically removed the K63-linked ubiquitin chain promoting the deacetylase activity of HDAC1. As a result, HDAC1 was able to deacetylate H3K56. USP38 deletion resulted in persistent focal accumulation of nonhomologous end joining (NHEJ) factors at DNA damage sites and impaired NHEJ efficiency, causing genome instability and sensitizing cancer cells to genotoxic insults. Knockout of USP38 rendered mice hypersensitive to irradiation and shortened survival. In addition, USP38 was expressed at low levels in certain types of cancers including renal cell carcinoma, indicating dysregulation of USP38 expression contributes to genomic instability and may lead to tumorigenesis. In summary, this study identifies a critical role of USP38 in modulating genome integrity and cancer cell resistance to genotoxic insults by deubiquitinating HDAC1 and regulating its deacetylation activity.Significance:This study demonstrates that USP38 regulates genome stability and mediates cancer cell resistance to DNA-damaging therapy, providing insight into tumorigenesis and implicating USP38 as a potential target for cancer diagnosis.
The deubiquitinase USP38 promotes NHEJ repair through regulation of HDAC1 activity and regulates cancer cell response to genotoxic insults.

Yongfeng Yang,Chuanzhen Yang,Tingting Li,Shuyu Yu,Tingting Gan,Jiazhi Hu,Jun Cui,Xiaofeng Zheng

DOI: https://doi.org/10.1158/0008-5472.CAN-19-2149

IF: 11.2

2020-01-01

Cancer Research

Abstract:The DNA damage response (DDR) is essential for maintaining genome integrity. Mounting evidence reveals that protein modifications play vital roles in the DDR. Here, we show that USP38 is involved in the DDR by regulating the activity of HDAC1. In response to DNA damage, USP38 interacted with HDAC1 and specifically removed the K63-linked ubiquitin chain promoting the deacetylase activity of HDAC1. As a result, HDAC1 was able to deacetylate H3K56. USP38 deletion resulted in persistent focal accumulation of nonhomologous end joining (NHEJ) factors at DNA damage sites and impaired NHEJ efficiency, causing genome instability and sensitizing cancer cells to genotoxic insults. Knockout of USP38 rendered mice hypersensitive to irradiation and shortened survival. In addition, USP38 was expressed at low levels in certain types of cancers including renal cell carcinoma, indicating dysregulation of USP38 expression contributes to genomic instability and may lead to tumorigenesis. In summary, this study identifies a critical role of USP38 in modulating genome integrity and cancer cell resistance to genotoxic insults by deubiquitinating HDAC1 and regulating its deacetylation activity. Significance: This study demonstrates that USP38 regulates genome stability and mediates cancer cell resistance to DNAdamaging therapy, providing insight into tumorigenesis and implicating USP38 as a potential target for cancer diagnosis.
Supplementary Table 1, Figures 1-7, Methods from hPuf-A/KIAA0020 Modulates PARP-1 Cleavage upon Genotoxic Stress

Hao-Yen Chang,Chi-Chen Fan,Po-Chen Chu,Bo-En Hong,Hyeon Jeong Lee,Mau-Sun Chang

DOI: https://doi.org/10.1158/0008-5472.22386603.v1

2023-01-01

Abstract:Supplementary Table 1, Figures 1-7, Methods from hPuf-A/KIAA0020 Modulates PARP-1 Cleavage upon Genotoxic Stress
USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses

Qiang Zou,Jin Jin,Hongbo Hu,Haiyan S Li,Simona Romano,Yichuan Xiao,Mako Nakaya,Xiaofei Zhou,Xuhong Cheng,Peirong Yang,Guillermina Lozano,Chengming Zhu,Stephanie S Watowich,Stephen E Ullrich,Shao-Cong Sun

DOI: https://doi.org/10.1038/ni.2885

IF: 30.5

2014-01-01

Nature Immunology

Abstract:Sun and colleagues show that the deubiquitinase USP15 stabilizes expression of the E3 ubiquitin ligase MDM2 in T cells, which results in inhibition of T cell activation, and in cancer cells, which results in survival of cancer cells.
USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

Yang Su,Chenming Wu,Yiming Chang,Lei Li,Yuping Chen,Xuebing Jia,Xinshu Wang,Ying Lv,Bentong Yu,Jian Yuan

DOI: https://doi.org/10.1007/s10549-022-06711-3

2022-01-01

Breast Cancer Research and Treatment

Abstract:Purpose Sirtuin7 (SIRT7), as a member of the sirtuin and NAD + -dependent protein-modifying enzyme family, plays an important role in regulating cellular metabolism, stress responses, tumorigenesis, and aging. Ubiquitination and deubiquitination are reversible post-translational modifications that regulate protein stability, enzyme activity, protein–protein interactions, and cellular signaling transduction. However, whether SIRT7 is regulated by deubiquitination signaling is unclear. This study aims to elucidate the molecular mechanism of SIRT7 via deubiquitination signaling. Methods USP17L2 or SIRT7-targeting shRNAs were used to deplete USP17L2 or SIRT7. Western blot was applied to assess the effects of USP17L2 or SIRT7 depletion. A co-immunoprecipitation assay was used to detect the interaction relationship. Cell Counting Kit-8 assays were applied to assess the viability of breast cancer cells. An immunohistochemistry assay was employed to detect the protein level in samples from breast cancer patients, and the TCGA database was applied to analyze the survival rate of breast cancer patients. Statistical analyses were performed with the Student’s t test (two-tailed unpaired) and χ 2 test. Results We find that the deubiquitinase USP17L2 interacts with and deubiquitinates SIRT7, thereby increasing SIRT7 protein stability. In addition, USP17L2 regulates DNA damage repair through SIRT7. Furthermore, SIRT7 polyubiquitination is increased by knocking down of USP17L2, which leads to cancer cells sensitizing to chemotherapy. In breast cancer patient samples, high expression of USP17L2 is correlated with increased levels of SIRT7 protein. In conclusion, our study demonstrates that the USP17L2-SIRT7 axis is the new regulator in DNA damage response and chemo-response, suggesting that USP17L2 may be a prognostic factor and a potential therapeutic target in breast cancer. Conclusion Our results highlighted that USP17L2 regulates the chemoresistance of breast cancer cells in a SIRT7-dependent manner. Moreover, the role of USP17L2 as a potential therapeutic target in breast cancer and a prognostic factor for patients was elucidated.
Correction to: USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization

Chenming Wu,Kuntian Luo,Fei Zhao,Ping Yin,Ying Song,Min Deng,Jinzhou Huang,Yuping Chen,Lei Li,SeungBaek Lee,JungJin Kim,Qin Zhou,Xinyi Tu,Somaira Nowsheen,Qifeng Luo,Xiumei Gao,Zhenkun Lou,Zhongmin Liu,Jian Yuan

DOI: https://doi.org/10.1038/s41418-018-0138-z

IF: 12.067

2022-01-01

Cell Death and Differentiation

Abstract:β-catenin is a major transcriptional activator of the canonical Wnt/β-catenin signaling pathway. It is important for a series of biological processes including tissue homeostasis, and embryonic development and is involved in various human diseases. Elevated oncogenic activity of β-catenin is frequently observed in cancers, which contributes to survival, metastasis and chemo-resistance of cancer cells. However, the mechanism of β-catenin overexpression in cancers is not well defined. Here we demonstrate that the deubiquitination enzyme USP20 is a new regulator of the Wnt/β-catenin signaling pathway. Mechanistically, USP20 regulates the deubiquitination of β-catenin to control its stability, thereby inducing proliferation, invasion and migration of cancer cells. High expression of USP20 correlates with increased β-catenin protein level in multiple cancer cell lines and patient samples. Moreover, knockdown of USP20 increases β-catenin polyubiquitination, which enhances β-catenin turnover and cell sensitivity to chemotherapy. Collectively, our results establish the USP20-β-catenin axis as a critical regulatory mechanism of canonical Wnt/β-catenin signaling pathway with an important role in tumorigenesis and chemo response in human cancers.
USP39 Regulates DNA Damage Response and Chemo-Radiation Resistance by Deubiquitinating and Stabilizing CHK2.

Jinhuan Wu,Yuping Chen,Guohe Geng,Lei Li,Ping Yin,Somaira Nowsheen,Yunhui Li,Chenming Wu,Jiaqi Liu,Fei Zhao,Wootae Kim,Qin Zhou,Jinzhou Huang,Guijie Guo,Chao Zhang,Xinyi Tu,Xiumei Gao,Zhenkun Lou,Kuntian Luo,Haixuan Qiao,Jian Yuan

DOI: https://doi.org/10.1016/j.canlet.2019.02.015

IF: 9.756

2019-01-01

Cancer Letters

Abstract:The serine/threonine kinase, CHK2 (checkpoint kinase 2), is a key mediator in DNA damage response and a tumor suppressor, which is implicated in promoting cell cycle arrest, apoptosis and DNA repair. Accumulating evidence suggests that these functions are primarily exerted through phosphorylation downstream factors such as p53 and BRCA1. Recent studies have shown that ubiquitination is an important mode of regulation of CHK2. However, it remains largely unclear whether deubiquitinases participate in regulation of CHK2. Here, we report that a deubiquitinase, USP39, is a new regulator of CHK2. Mechanistically, USP39 deubiquitinates and stabilizes CHK2, which in turn enhances CHK2 stability. Short hairpin RNA (shRNA) mediated knockdown of USP39 led to deregulate CHK2, which resulted in compromising the DNA damage-induced G2/M checkpoint, decreasing apoptosis, and conferring cancer cells resistance to chemotherapy drugs and radiation treatment. Collectively, we identify USP39 as a novel regulator of CHK2 in the DNA damage response.
Supplementary Fig.4 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507974.v1

2023-01-01

Abstract:Nuclear p53 plays a critical role in synergistic cytotoxic effect in RKO cells.
USP25 Elevates SHLD2‐Mediated DNA Double‐Strand Break Repair and Regulates Chemoresponse in Cancer

Yunhui Li,Lei Li,Xinshu Wang,Fei Zhao,Yuntong Yang,Yujuan Zhou,Jiyuan Zhang,Li Wang,Zeshan Jiang,Yuanyuan Zhang,Yuping Chen,Chenming Wu,Ke Li,Tingting Zhang,Ping Wang,Zhiyong Mao,Weiguo Zhu,Xingzhi Xu,Shikang Liang,Zhenkun Lou,Jian Yuan

DOI: https://doi.org/10.1002/advs.202403485

IF: 15.1

2024-05-29

Advanced Science

Abstract:USP25 deubiquitinates SHLD2 at the K64 site, which enhances its binding with REV7 and promotes NHEJ pathway. A peptide is identified to disrupt the USP25‐SHLD2 interaction, impair NHEJ pathway, and increase sensitivity to chemotherapy in PDX model, thereby proposing a potential therapeutic strategy for cancer therapy. DNA damage plays a significant role in the tumorigenesis and progression of the disease. Abnormal DNA repair affects the therapy and prognosis of cancer. In this study, it is demonstrated that the deubiquitinase USP25 promotes non‐homologous end joining (NHEJ), which in turn contributes to chemoresistance in cancer. It is shown that USP25 deubiquitinates SHLD2 at the K64 site, which enhances its binding with REV7 and promotes NHEJ. Furthermore, USP25 deficiency impairs NHEJ‐mediated DNA repair and reduces class switch recombination (CSR) in USP25‐deficient mice. USP25 is overexpressed in a subset of colon cancers. Depletion of USP25 sensitizes colon cancer cells to IR, 5‐Fu, and cisplatin. TRIM25 is also identified, an E3 ligase, as the enzyme responsible for degrading USP25. Downregulation of TRIM25 leads to an increase in USP25 levels, which in turn induces chemoresistance in colon cancer cells. Finally, a peptide that disrupts the USP25‐SHLD2 interaction is successfully identified, impairing NHEJ and increasing sensitivity to chemotherapy in PDX model. Overall, these findings reveal USP25 as a critical effector of SHLD2 in regulating the NHEJ repair pathway and suggest its potential as a therapeutic target for cancer therapy.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507968.v1

2023-01-01

Abstract:Bortezomib and KPT330 co-treatment inhibit patients-derived xenografts in nude mice.
Supplementary Data 2 from GTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress

Weihua Zhou,Zitong Zhao,Angelica Lin,John Z. Yang,Jie Xu,Kari Wilder-Romans,Annabel Yang,Jing Li,Sumeet Solanki,Jennifer M. Speth,Natalie Walker,Andrew J. Scott,Lu Wang,Bo Wen,Anthony Andren,Li Zhang,Ayesha U. Kothari,Yangyang Yao,Erik R. Peterson,Navyateja Korimerla,Christian K. Werner,Alexander Ullrich,Jessica Liang,Janna Jacobson,Sravya Palavalasa,Alexandra M. O’Brien,Ameer L. Elaimy,Sean P. Ferris,Shuang G. Zhao,Jann N. Sarkaria,Balázs Győrffy,Shuqun Zhang,Wajd N. Al-Holou,Yoshie Umemura,Meredith A. Morgan,Theodore S. Lawrence,Costas A. Lyssiotis,Marc Peters-Golden,Yatrik M. Shah,Daniel R. Wahl

DOI: https://doi.org/10.1158/2159-8290.24988565.v1

2024-01-01

Abstract:Supplementary Data 2 shows Supplementary Methods, Supplementary Reference, Supplementary Figure S1 and Figure Legends, Supplementary Figure S2 and Figure Legends, Supplementary Figure S3 and Figure Legends, Supplementary Figure S4 and Figure Legends, Supplementary Figure S5 and Figure Legends, Supplementary Figure S6 and Figure Legends, and Supplementary Figure S7 and Figure Legends.
Supplementary Methods and Figure Legends from USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity

Xing Huang,Qi Zhang,Yu Lou,Junli Wang,Xinyu Zhao,Lin Wang,Xiaozhen Zhang,Shanshan Li,Yulan Zhao,Qi Chen,Tingbo Liang,Xueli Bai

DOI: https://doi.org/10.1158/2326-6066.22542108

2023-01-01

Abstract:Supplementary Materials and Methods, and Supplementary Figure legends.
USP21 deubiquitylates Nanog to regulate protein stability and stem cell pluripotency (vol 1, e16024, 2016)

Xingyu Liu,Yuying Yao,Huiguo Ding,Chuanchun Han,Yuhan Chen,Yuan Zhang,Chanjuan Wang,Xin Zhang,Yiling Zhang,Yun Zhai,Ping Wang,Wenyi Wei,Jing Zhang,Lingqiang Zhang

DOI: https://doi.org/10.1038/sigtrans.2016.46

IF: 39.3

2017-01-01

Signal Transduction and Targeted Therapy

Abstract:[This corrects the article DOI: 10.1038/sigtrans.2016.24.].
USP37 Regulates DNA Damage Response Through Stabilizing and Deubiquitinating BLM

Chenming Wu,Yiming Chang,Junliang Chen,Yang Su,Lei Li,Yuping Chen,Yunhui Li,Jinhuan Wu,Jinzhou Huang,Fei Zhao,Wenrui Wang,Hui Yin,Shunli Wang,Mingpeng Jin,Zhenkun Lou,Wei-Guo Zhu,Kuntian Luo,Jie Zhang,Jian Yuan

DOI: https://doi.org/10.1093/nar/gkab842

IF: 14.9

2021-01-01

Nucleic Acids Research

Abstract:The human RecQ helicase BLM is involved in the DNA damage response, DNA metabolism, and genetic stability. Loss of function mutations in BLM cause the genetic instability/cancer predisposition syndrome Bloom syndrome. However, the molecular mechanism underlying the regulation of BLM in cancers remains largely elusive. Here, we demonstrate that the deubiquitinating enzyme USP37 interacts with BLM and that USP37 deubiquitinates and stabilizes BLM, thereby sustaining the DNA damage response (DDR). Mechanistically, DNA double-strand breaks (DSB) promotes ATM phosphorylation of USP37 and enhances the binding between USP37 and BLM. Moreover, knockdown of USP37 increases BLM polyubiquitination, accelerates its proteolysis, and impairs its function in DNA damage response. This leads to enhanced DNA damage and sensitizes breast cancer cells to DNA-damaging agents in both cell culture and in vivo mouse models. Collectively, our results establish a novel molecular mechanism for the USP37-BLM axis in regulating DSB repair with an important role in chemotherapy and radiotherapy response in human cancers.
De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity

Jingwei Liu,Tingting Zhou,Xiang Dong,Qiqiang Guo,Lixia Zheng,Xiaoxun Wang,Naijin Zhang,Danni Li,Ling Ren,Fei Yi,Ying Zhang,Ziwei Li,Xiwen Wang,Chengsi Deng,Chunlu Li,Hongde Xu,Yi Guan,Xiaoman Li,Yang Yu,Wendong Guo,Zhuo Wang,Bo Jiang,Xuan Wu,Ning Bai,Yanling Feng,Mengtao Ma,Qingquan Kong,Jiayi Wei,Zhenshuang Wang,Hao Li,Songming Lu,Liangzi Cao,Yutong Xiao,Xiaoyu Song,Zhenning Wang,Chengzhong Xing,Liu Cao

DOI: https://doi.org/10.1038/s41388-023-02667-w

IF: 8.756

2023-04-21

Oncogene

Abstract:Oncogenic stress induces DNA damage repair (DDR) that permits escape from mitotic catastrophe and allows early precursor lesions during the evolution of cancer. SAMHD1, a dNTPase protecting cells from viral infections, has been recently found to participate in DNA damage repair process. However, its role in tumorigenesis remains largely unknown. Here, we show that SAMHD1 is up-regulated in early-stage human carcinoma tissues and cell lines under oxidative stress or genotoxic insults. We further demonstrate that de-ubiquitinating enzyme USP7 interacts with SAMHD1 and de-ubiquitinates it at lysine 421, thus stabilizing SAMHD1 protein expression for further interaction with CtIP for DDR, which promotes tumor cell survival under genotoxic stress. Furthermore, SAMHD1 levels positively correlates with USP7 in various human carcinomas, and is associated with an unfavorable survival outcome in patients who underwent chemotherapy. Moreover, USP7 inhibitor sensitizes tumor cells to chemotherapeutic agents by decreasing SAMHD1 in vitro and in vivo. These findings suggest that de-ubiquitination of SAMHD1 by USP7 promotes DDR to overcome oncogenic stress and affect chemotherapy sensitivity.

oncology,genetics & heredity,biochemistry & molecular biology,cell biology
Correction: Corrigendum: Lysine Acetylation and Succinylation in HeLa Cells and Their Essential Roles in Response to UV-induced Stress

Hong Xu,Xuanyi Chen,Xin Xu,Rongyi Shi,Shasha Suo,Kaiying Cheng,Zhong Zheng,Meixia Wang,Liangyan Wang,Ye Zhao,Bing Teng,Yuejin Hua

DOI: https://doi.org/10.1038/srep46831

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 30212; published online: 25 July 2016; updated: 26 May 2017. In the original version of this Article, Supplementary Datasets 1, 2, 3, 4 and 5 were omitted. The correct Supplementary Datasets now accompany the Article.
Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Alfred S.L. Cheng,Suki S. Lau,Yangchao Chen,Yutaka Kondo,May S. Li,Hai Feng,Arthur K. Ching,Kin F. Cheung,Hoi K. Wong,Joanna H. Tong,Hongchuan Jin,Kwong W. Choy,Jun Yu,Ka F. To,Nathalie Wong,Tim H.-M. Huang,Joseph J.Y. Sung

DOI: https://doi.org/10.1158/0008-5472.22395239.v1

2023-01-01

Abstract:Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes β-Catenin–Dependent Hepatocarcinogenesis
Supplementary Data from Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis

Yinyin Shu,Xiaoni Jin,Mintao Ji,Zhisen Zhang,Xiuxiu Wang,Haisheng Liang,Shuangshuang Lu,Shuai Dong,Yiping Lin,Yuhan Guo,Qiuyu Zhuang,Yuhong Wang,Zhe Lei,Lingchuan Guo,Xuanyu Meng,Guangming Zhou,Wensheng Zhang,Lei Chang

DOI: https://doi.org/10.1158/0008-5472.26934796.v1

2024-01-01

Abstract:Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6, Figure S7, Figure S8
Regulation of XPC deubiquitination by USP11 in repair of UV-induced DNA damage.

Palak Shah,Lei Qiang,Seungwon Yang,Keyoumars Soltani,Yu-Ying He

DOI: https://doi.org/10.18632/oncotarget.22105

2017-01-01

Oncotarget

Abstract:Nucleotide excision repair (NER) is the most versatile DNA repair pathway for removing DNA damage caused by UV radiation and many environmental carcinogens. NER is essential for suppressing tumorigenesis in the skin, lungs and brain. Although the core NER proteins have been identified and characterized, molecular regulation of NER remains poorly understood. Here we show that ubiquitin-specific peptidase 11 (USP11) positively regulates NER by deubiquitinating xeroderma pigmentosum complementation group C (XPC) and promoting its retention at the DNA damage sites. In addition, UV irradiation induces both USP11 recruitment to the chromatin and USP11 interaction with XPC in an XPC-ubiquitination-dependent manner. Furthermore, we found that USP11 is down-regulated in chronically UV-exposed mouse skin and in skin tumors from mice and humans. Our findings indicate that USP11 plays an important role in maintaining NER capacity, and suggest that USP11 acts as a tumor suppressor via its role in DNA repair.
Supplementary Figures S1-S8 from USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity

Xing Huang,Qi Zhang,Yu Lou,Junli Wang,Xinyu Zhao,Lin Wang,Xiaozhen Zhang,Shanshan Li,Yulan Zhao,Qi Chen,Tingbo Liang,Xueli Bai

DOI: https://doi.org/10.1158/2326-6066.22542111.v1

2023-01-01

Abstract:This file contains supplemental figures S1-S8, and the detailed description is as follows: Figure S1 shows USP22 binding to HLEET motif of CD274. Figure S2 shows USP22 stabilizing CD274 in CDK4-independent manner. Figure S3 shows the non-requirement of CD274 for USP22-controlled cancer cell growth in vitro. Figure S4 shows the expression profile of USP22 in multiple cancers. Figure S5 shows the CD274-independent roles of USP22 in liver cancer growth and therapy. Figure S6 shows the expression levels of CD274 in USP22-regulated tumor immunity. Figure S7 shows the negative correlation of USP22 and immune signatures in LIHC. Figure S8 shows the schematic model.

Supplementary Data from the Deubiquitinase USP38 Promotes NHEJ Repair Through Regulation of HDAC1 Activity and Regulates Cancer Cell Response to Genotoxic Insults

Data from The Deubiquitinase USP38 Promotes NHEJ Repair through Regulation of HDAC1 Activity and Regulates Cancer Cell Response to Genotoxic Insults

The deubiquitinase USP38 promotes NHEJ repair through regulation of HDAC1 activity and regulates cancer cell response to genotoxic insults.

Supplementary Table 1, Figures 1-7, Methods from hPuf-A/KIAA0020 Modulates PARP-1 Cleavage upon Genotoxic Stress

USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses

USP17L2-SIRT7 axis regulates DNA damage repair and chemoresistance in breast cancer cells

Correction to: USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization

USP39 Regulates DNA Damage Response and Chemo-Radiation Resistance by Deubiquitinating and Stabilizing CHK2.

Supplementary Fig.4 from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

USP25 Elevates SHLD2‐Mediated DNA Double‐Strand Break Repair and Regulates Chemoresponse in Cancer

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplementary Data 2 from GTP Signaling Links Metabolism, DNA Repair, and Responses to Genotoxic Stress

Supplementary Methods and Figure Legends from USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity

USP21 deubiquitylates Nanog to regulate protein stability and stem cell pluripotency (vol 1, e16024, 2016)

USP37 Regulates DNA Damage Response Through Stabilizing and Deubiquitinating BLM

De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity

Correction: Corrigendum: Lysine Acetylation and Succinylation in HeLa Cells and Their Essential Roles in Response to UV-induced Stress

Supplementary Methods, Figures 1-9, Tables 2-6 from EZH2-Mediated Concordant Repression of Wnt Antagonists Promotes Β-Catenin–dependent Hepatocarcinogenesis

Supplementary Data from Ku70 Binding to YAP Alters PARP1 Ubiquitination to Regulate Genome Stability and Tumorigenesis

Regulation of XPC deubiquitination by USP11 in repair of UV-induced DNA damage.

Supplementary Figures S1-S8 from USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity